The Committee has received written submissions from NICE, NHS England and Vertex Pharmaceuticals, as can be seen in the correspondence published here. It has also published a number of other written submissions here. It took oral evidence from representatives of NHS England, NICE and Vertex Pharmaceuticals, as well as from representatives of patients and clinicians, on Thursday 7 March 2019.
The Committee is currently awaiting updates on the progress of ongoing negotiations between NHS England and Vertex Pharmaceuticals. Find the received updates below:
The Committee's response to the updates can be found here